|
Peptide Name
|
CAT#
|
Peptide Sequence
|
|
A-18-F-NH2 Morphine Modulating Neuropeptide
|
1959-1-1
|
Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2
|
|
Alytesin
|
1959-1-2
|
Glp-Gly-Arg-Leu-Gly-Thr-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
|
|
Buccalin
|
1959-1-3
|
Gly-Met-Asp-Ser-Leu-Ala-Phe-Ser-Gly-Gly-Leu-NH2
|
|
Catch-Relaxing Peptide (CARP)
|
1959-1-4
|
Ala-Met-Pro-Met-Leu-Arg-Leu-NH2
|
|
Cerebellin
|
1959-1-5
|
Ser-Gly-Ser-Ala-Lys-Val-Ala-Phe-Ser-Ala-Ile-Arg-Ser-Thr-Asn-His
|
|
Corazonin
|
1959-1-6
|
Glp-Thr-Phe-Gln-Tyr-Ser-Arg-Gly-Trp-Thr-Asn-NH2
|
|
Cortistatin-17 human
|
1959-1-7
|
Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys
|
|
Diazepam-Binding Inhibitor Fragment human
|
1959-1-8
|
Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr-Gly-Lys
|
|
Eledoisin
|
1959-1-9
|
Glp-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2
|
|
Eledoisin Related Peptide
|
1959-1-10
|
Lys-Phe-Ile-Gly-Leu-Met-NH2
|
|
g-Neuropeptide rabbit
|
1959-1-11
|
Asp-Ala-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2
|
|
Granuliberin R
|
1959-1-12
|
Phe-Gly-Phe-Leu-Pro-Ile-Tyr-Arg-Arg-Pro-Ala-Ser-NH2
|
|
Head Activator Neuropeptide
|
1959-1-13
|
Glp-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe
|
|
Histine-Rich Basic Peptide (HRBP)(Aplysia californica)
|
1959-1-14
|
Glp-Val-Ala-Gln-Met-His-Val-Trp-Arg-Ala-Val-Asn-His-Asp-Arg-Asn-His-Gly-Thr-Gly-Ser-Gly-Arg-His-Gly-Arg-Phe-Leu-Ile-Arg-Asn-Arg-Tyr-Arg-Tyr-Gly-Gly-Gly-His-Leu-Ser-Asp-Ala
|
|
Kassinin
|
1959-1-15
|
Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH2
|
|
Kinetensin
|
1959-1-16
|
Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu
|
|
Levitide
|
1959-1-17
|
Glp-Gly-Met-Ile-Gly-Thr-Leu-Thr-Ser-Lys-Arg-Ile-Lys-Gln-NH2
|
|
Litorin
|
1959-1-18
|
Glp-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2
|
|
Mastoparan
|
1959-1-19
|
Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2
|
|
Mastoparan X
|
1959-1-20
|
Ile-Asn-Trp-Lys-Gly-Ile-Ala-Ala-Met-Ala-Lys-Lys-Leu-Leu-NH2
|
|
Melanostatin frog
|
1959-1-21
|
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Lys-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
|
|
Men 10376
|
1959-1-22
|
Asp-Tyr-DTrp-Val-DTrp-DTrp-Lys-NH2
|
|
Neuron Specific Peptide
|
1959-1-23
|
Asp-Val-Ser-Asp-Gly-Ser-Ala-Glu-Arg-Arg-Pro-Tyr-Thr-Arg-Met-Gly-Ser-Gly-Gly-Leu-Lys-Leu-His-Cys-Val-His-Pro-Ala-Asn-Cys-Pro-Gly-Gly-Leu-Met-Val-Thr
|
|
Neuropeptide EI-Gly-Arg-Arg-MCH human mouse rat
|
1959-1-24
|
Glu-Ile-Gly-Asp-Glu-Glu-Asn-Ser-Ala-Lys-Phe-Pro-Ile-Gly-Arg-Arg-Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val
|
|
Neuropeptide FF Morphine Modulating Neuropeptide
|
1959-1-25
|
Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2
|
|
Neuropeptide K porcine
|
1959-1-26
|
Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2
|
|
Neuropeptide S rat
|
1959-1-27
|
Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Val-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln
|
|
Nocistatin
|
1959-1-28
|
Glu-Gln-Lys-Gln-Leu-Gln
|
|
Phyllomedusin
|
1959-1-29
|
Glp-Asn-Pro-Asn-Arg-Phe-Ile-Gly-Leu-Met-NH2
|
|
Physalaemin
|
1959-1-30
|
Glp-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2
|
|
Polistes Mastoparan
|
1959-1-31
|
Val-Asp-Trp-Lys-Lys-Ile-Gly-Gln-His-Ile-Leu-Ser-Val-Leu-NH2
|
|
Proctolin
|
1959-2-1
|
Arg-Tyr-Leu-Pro-Thr
|
|
Ranatensin
|
1959-2-2
|
Glp-Val-Pro-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2
|
|
Tachykinin (111-129) Beta-Prepro (Human)
|
1959-2-3
|
Ala-Leu-Asn-Ser-Val-Ala-Tyr-Glu-Arg-Ser-Ala-Met-Gln-Asn-Tyr-Glu-Arg-Arg-Arg
|
|
Tyr-W-MIF-1
|
1959-2-4
|
Tyr-Pro-Trp-Gly-NH2
|
|
Uperolein
|
1959-2-5
|
Glp-Pro-Asp-Pro-Asn-Ala-Phe-Tyr-Gly-Leu-Met-NH2
|
|
Xenopsin
|
1959-2-6
|
Glp-Gly-Lys-Arg-Pro-Trp-Ile-Leu
|
|
Xenopsin-related Peptide I
|
1959-2-7
|
Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu
|
|
Xenopsin-related Peptide II
|
1959-2-8
|
His-Pro-Lys-Arg-Pro-Trp-Ile-Leu
|
|
[Des-Ser1] Cerebellin
|
1959-2-9
|
Gly-Ser-Ala-Lys-Val-Ala-Phe-Ser-Ala-Ile-Arg-Ser-Thr-Asn-His
|
|
[His7] Corazonin
|
1959-2-10
|
Glp-Thr-Phe-Gln-Tyr-Ser-His-Gly-Trp-Thr-Asn-NH2
|
